Skip to content

Member

Borys BUDKA

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
84.6 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
91.1 %ⓘ of 5 015 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
KO Koalicja Obywatelska
In office
Since 16 Jul 2024
Against clear line
281 of 4 760 votesⓘ
Committees
EMPL (substitute), ITRE (chair)
Member id
257047
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

84.6 %

5 015 of 5 928 roll calls while in office

EPP median: 89.9 % (−5.3 pts)

Chamber median: 90.2 %

With majority line ⓘ

91.1 %

4 568 of 5 015 votes where their group had a line

EPP median: 93.6 % (−2.5 pts)

Against clear line ⓘ

5.9 %

281 of 4 760 votes where their group had a clear line

205 opposite (for ↔ against), 74 abstained against the line, 2 voted for or against when the line was to abstain

Abstention ⓘ

2.5 %

126 of 5 015 votes cast

Participation 84.6 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Borys BUDKA84.6 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 91.1 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Borys BUDKA91.1 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Adopted 459 for, 12 against, 86 abstainedPosition: For Majority line: For
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Adopted 374 for, 198 against, 19 abstainedPosition: For Majority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Adopted 514 for, 61 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Adopted 562 for, 1 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Adopted 395 for, 136 against, 80 abstainedPosition: For Majority line: For
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Adopted 467 for, 92 against, 44 abstainedPosition: For Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Adopted 368 for, 172 against, 69 abstainedPosition: For Majority line: For
17 Sept 2026Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers Adopted 601 for, 4 against, 5 abstainedPosition: For Majority line: For
17 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders Adopted 339 for, 225 against, 16 abstainedPosition: No vote recorded Majority line: For
17 Sept 2026Strengthening global health resilience in partner countries Adopted 319 for, 142 against, 19 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) Passed 549 for, 92 against, 27 abstainedPosition: For Majority line: For
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) Passed 540 for, 105 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Passed 530 for, 125 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Passed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Passed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Passed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Consent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Consent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Objection passed 442 for, 184 against, 12 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Genetically modified soybean MON 94313 Objection passed 457 for, 184 against, 10 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Genetically modified maize MON 87460 Objection passed 433 for, 159 against, 10 abstainedPosition: For Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Adopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Adopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Adopted 390 for, 218 against, 29 abstainedPosition: For Majority line: Against
15 Sept 2026Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures Passed 464 for, 50 against, 159 abstainedPosition: For Majority line: For
15 Sept 2026Establishing the Temporary Decarbonisation Fund Passed 433 for, 97 against, 146 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances Passed 367 for, 240 against, 59 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the buildings, road transport and additional sectors Passed 467 for, 158 against, 41 abstainedPosition: For Majority line: For
15 Sept 2026Implementation into Union law of measures adopted by regional fisheries management organisations Passed 559 for, 48 against, 62 abstainedPosition: For Majority line: For
15 Sept 2026General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area Passed 580 for, 51 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Temporary trade-liberalisation measures applicable to Armenian products Passed 583 for, 49 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure Passed 440 for, 127 against, 104 abstainedPosition: For Majority line: For
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield Adopted 420 for, 220 against, 26 abstainedPosition: For Majority line: For
15 Sept 2026Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee Adopted 530 for, 77 against, 61 abstainedPosition: For Majority line: For
15 Sept 2026The EU Youth Strategy 2019–2027 Adopted 477 for, 124 against, 66 abstainedPosition: For Majority line: For
15 Sept 2026Global role of the euro Adopted 405 for, 146 against, 60 abstainedPosition: For Majority line: For
9 Jul 2026Establishment of the digital euro Negotiating mandate approved 416 for, 169 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Adopted 476 for, 28 against, 96 abstainedPosition: For Majority line: For
9 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Adopted 510 for, 1 against, 86 abstainedPosition: For Majority line: For
9 Jul 2026Feasibility of a 28th tax regime and its potential to support EU competitiveness Adopted 366 for, 192 against, 39 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement Consent given 479 for, 119 against, 65 abstainedPosition: For Majority line: For
8 Jul 2026Protection of the environment through criminal law Consent given 499 for, 99 against, 69 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Interim Agreement on Trade Consent given 474 for, 131 against, 60 abstainedPosition: For Majority line: For
8 Jul 2026EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol) Consent given 625 for, 16 against, 20 abstainedPosition: For Majority line: For
8 Jul 2026EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement Consent given 573 for, 35 against, 37 abstainedPosition: For Majority line: For
8 Jul 2026Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets Objection passed 388 for, 248 against, 24 abstainedPosition: For Majority line: For
8 Jul 2026Lead in certain fishing tackle Objection failed 197 for, 455 against, 7 abstainedPosition: Against Majority line: Against
8 Jul 2026Genetically modified maize NK603 × T25 Objection passed 460 for, 189 against, 14 abstainedPosition: For Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 25 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202420
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241313
13 Nov 202422
14 Nov 20243635
25 Nov 202420
26 Nov 20241818
27 Nov 20241111
28 Nov 20245753
17 Dec 2024130
18 Dec 20243331
19 Dec 20244542
20 Jan 202520
21 Jan 202511
22 Jan 202522
23 Jan 20254541
10 Feb 202511
11 Feb 2025321
12 Feb 20251010
13 Feb 20253029
10 Mar 202520
11 Mar 202590
12 Mar 20252280
13 Mar 20252422
31 Mar 202533
1 Apr 20253534
2 Apr 2025251246
3 Apr 20256261
5 May 202555
6 May 20251010
7 May 2025220209
8 May 2025103100
21 May 202520
22 May 20255351
16 Jun 202522
17 Jun 20254140
18 Jun 20259188
19 Jun 20258783
7 Jul 202510
8 Jul 2025550
9 Jul 20251340
10 Jul 2025360
8 Sept 202511
9 Sept 202510198
10 Sept 20253434
11 Sept 20256967
6 Oct 202520
7 Oct 202555
8 Oct 20255555
9 Oct 20256565
20 Oct 202530
21 Oct 2025130
22 Oct 2025186157
23 Oct 20255555
13 Nov 2025267244
24 Nov 202533
25 Nov 20257572
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202544
16 Dec 20256666
17 Dec 20254342
18 Dec 20254241
20 Jan 20266763
21 Jan 2026112105
22 Jan 20265853
9 Feb 202620
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141137
24 Feb 2026430
9 Mar 202610
10 Mar 2026197181
11 Mar 20266056
12 Mar 20263434
25 Mar 202630
26 Mar 2026690
27 Apr 202620
28 Apr 2026225218
29 Apr 2026296279
30 Apr 20266867
18 May 202640
19 May 202633
20 May 20269693
21 May 20269850
15 Jun 202620
16 Jun 20264040
17 Jun 2026127124
18 Jun 20267771
6 Jul 202620
7 Jul 20267272
8 Jul 2026144139
9 Jul 20266766
14 Sept 202610
15 Sept 2026155151
16 Sept 20268079
17 Sept 2026124121

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Andrzej HALICKI EPPPoland96 % of 4 569 shared89 %
Krzysztof BREJZA EPPPoland96 % of 4 626 shared89 %
Ewa KOPACZ EPPPoland96 % of 5 004 shared89 %
Andrzej BUŁA EPPPoland96 % of 4 577 shared89 %
Mirosława NYKIEL EPPPoland96 % of 4 426 shared89 %
Jagna MARCZUŁAJTIS-WALCZAK EPPPoland96 % of 4 688 shared89 %
Michał WAWRYKIEWICZ EPPPoland96 % of 4 507 shared89 %
Magdalena ADAMOWICZ EPPPoland96 % of 4 737 shared89 %
Bogdan Andrzej ZDROJEWSKI EPPPoland96 % of 4 980 shared89 %
Łukasz KOHUT EPPPoland96 % of 4 857 shared89 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Dan BARNA RenewRomania83 % of 4 364 shared82 %
Urmas PAET RenewEstonia83 % of 4 490 shared82 %
Eugen TOMAC RenewRomania83 % of 3 523 shared82 %
Dan NICA S&DRomania82 % of 2 876 shared75 %
Hilde VAUTMANS RenewBelgium82 % of 4 836 shared82 %
Katri KULMUNI RenewFinland82 % of 3 926 shared82 %
Jérémy DECERLE RenewFrance82 % of 2 756 shared82 %
Nathalie LOISEAU RenewFrance82 % of 3 938 shared82 %
Ivars IJABS RenewLatvia82 % of 3 725 shared82 %
Grégory ALLIONE RenewFrance82 % of 4 225 shared82 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Employment and Social AffairsEMPL CommitteeSubstitute19 Jul 2024now
Committee on Industry, Research and EnergyITRE CommitteeChair23 Jul 2024now
Delegation for relations with Australia and New ZealandDANZ DelegationMember19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 202422 Jul 2024

Show all 5 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationITRE29 Jun 2026
Agreement between the European Union and Canada laying down the conditions for the participation of Canadian legal entities and products originating in Canada to procurement under the SAFE InstrumentRapporteurITRE20 Apr 2026
No dossier namedOfficial delegationITRE15 Apr 2026
On the adoption of the Research Programme of the Research Fund for Coal and Steel, on the multiannual technical guidelines for this programme, on the multiannual financial guidelines for managing the assets of the Research Fund for Coal and Steel, and repealing Decisions 2003/77/EC and 2008/376/ECRapporteurITRE6 Mar 2026
Agreement between the European Union and the Republic of Lebanon, in the form of an Exchange of Letters, amending and supplementing the Agreement for scientific and technological cooperation between the European Union and the Republic of Lebanon, setting out the terms and conditions for the participation of the Republic of Lebanon in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA)RapporteurITRE29 Jan 2026
No dossier namedOfficial delegationITRE15 Jan 2026
No dossier namedOpinion rapporteurITRE13 Nov 2025
Amending Council Regulation (EU) 2021/1173 of 13 July 2021 on establishing the European High Performance Computing Joint Undertaking and repealing Regulation (EU) 2018/1488RapporteurITRE17 Oct 2025
EU-Switzerland Cooperation Agreement on the European Satellite Navigation ProgrammesRapporteurITRE2 Jul 2025
Renewal of the Agreement for scientific and technological cooperation between the European Community and the Government of the Republic of IndiaRapporteurITRE30 Jun 2025

Show all 20 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

9 contributions recorded; 1 on behalf of their group; 19 minutes of speaking time.

Show all 9 recent contributions

Questions and motions, 24

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
1 Jul 2026MOTION FOR A RESOLUTION on Commission delegated regulation of 10 April 2026 amending Commission Delegated Regulation (EU) 2019/807 to introduce a trajectory to gradually decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets B-10-2026-0337Motion for a resolution—
29 Jun 2026Protecting minors online from manipulation, bullying and grooming E-10-2026-002680Written questionwith 9 co-authors11 Sept 2026
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
9 Jun 2026Chinese tomato concentrate imports: protecting EU producers and food security P-10-2026-002375Priority written questionwith 23 co-authors13 Jul 2026
25 Mar 2026Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255Written questionwith 17 co-authors19 Jun 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
14 Jan 2026MOTION FOR A RESOLUTION seeking an opinion from the Court of Justice on the compatibility with the Treaties of the proposed Partnership Agreement between the European Union and its Member States, of the one part, and the Common Market of the South, the Argentine Republic, the Federative Republic of Brazil, the Republic of Paraguay and the Oriental Republic of Uruguay, of the other part, and the proposed Interim Agreement on Trade between the European Union, of the one part, and the Common Market of the South, the Argentine Republic, the Federative Republic of Brazil, the Republic of Paraguay and the Oriental Republic of Uruguay, of the other part B-10-2026-0060Motion for a resolutionwith 143 co-authors—

Show all 24 questions and motions

Amendments tabled in committee, 67

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5314
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ536
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790099 CJ712

Show all 67 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Borys BUDKA”. Member record. memberId 257047. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257047?nb=all&scope=all&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257047. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257047?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257047,
  author = {{EU Parl Watch Research}},
  title = {{Borys BUDKA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257047?nb=all&scope=all&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/257047?nb=all&scope=all&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257047. Official source: https://www.europarl.europa.eu/meps/en/257047. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}